Entries by Art Flatau

Quizartinib in FLT3-ITD-Positive AML

Bookmark (0)

No account yet? Register

Introduction  I generally think of treatments for AML as old, meaning they were around when I was diagnosed in 1992, or new ones that were developed after that. In the […]

Ivosidenib and Azacitidine for IDH1-Mutated AML

Bookmark (0)

No account yet? Register

There has been another significant advance in the treatment of Acute Myeloid Leukemia (AML) at least for the small subset of patients (6-10%) who have a mutation in one of […]

Naïve T-cell Depletion in Donor Blood Stem Cell Transplant Patients 

Bookmark (0)

No account yet? Register

Introduction  T-cell depletion is a strategy to remove T-cells from bone marrow or peripheral stem cells taken from a donor before they are given to a patient. T-cell depletion (TCD) has […]

Low Testosterone in Cancer or Transplant Survivors

Bookmark (0)

No account yet? Register

I was one of the authors (out of more than 50) of a review article on male specific late effects in stem cell transplant patients [1]. The article looked at […]

Introducing Art Flatau, AML Empowerment Lead

Bookmark (0)

No account yet? Register

I have decided to try my hand at writing a regular blog.  I hope to write a post every month or so. This first post is something of an introduction.  […]